ReNeuron And CHEMICON International, Inc. Enter Into Agreement For Exclusive Sale And Marketing Of ReNcell Neural Stem Cell Lines

Published: Apr 18, 2006

ReNeuron Group plc (LSE: RENE.L) today announces that it has signed an agreement with Chemicon International, Inc. ('Chemicon'), a subsidiary of Serologicals Corporation (NASDAQ/NM: SERO), whereby Chemicon will exclusively manufacture and distribute two of ReNeuron's patented ReNcell neural stem cell lines worldwide for research purposes.

Back to news